The net revenue for Belviq was $9M+ for ~3.5 months. This quarter we are in Eisai will ship over 125K bottles.
Eisai has given Arena close to $200M so far and is spending $100M because they know the market is there, they have focused their efforts on getting traction with several thousand doctors that continues week after week, now they are also focusing on the consumer, soon with TV ads. TV ads that will be running during prime time, during sports games, during Women focused shows, etc. A year from now the awareness of Belviq will 1000X from what it is today among consumers.
BELVIQ WORKs! It works for weight loss, it works for improving glycemic control, it works for having people sleep better, the word that BELVIQ WORKs is spreading from patients to their friends, from Doctors to their colleagues. It is spreading, adjusted scripts are growing week by week.
The discussion by the shorts is how they move from a short position to a long position. Since going forward, they can make more money by being long since the upside will be higher on the upside. Yes, there will be still shorting that will take place but not at the same pace as before. In addition, besides the Belviq revenue, milestone revenue will be coming in over the next several months adding to Arena's revenues.
BELVIQ WORKs and there is no thesis that disputes that key fact - none!